Tranbaugh Robert F, Schwann Thomas A, Swistel Daniel G, Dimitrova Kamellia R, Al-Shaar Laila, Hoffman Darryl M, Geller Charles M, Engoren Milo, Balaram Sandhya K, Puskas John D, Habib Robert H
Department of Cardiovascular Surgery, Mount Sinai Beth Israel, New York, New York.
Division of Cardiothoracic Surgery, University of Toledo Medical Center, Toledo, Ohio.
Ann Thorac Surg. 2017 Aug;104(2):553-559. doi: 10.1016/j.athoracsur.2016.11.017. Epub 2017 Feb 16.
It is not clear whether radial artery (RA), right internal thoracic artery (RITA), or saphenous vein (SV) is the preferred second bypass graft during coronary artery bypass graft surgery using the left internal thoracic artery (LITA) in patients aged less or greater than 70 years.
Late survival data were collected for 13,324 consecutive, isolated, primary coronary artery bypass graft surgery patients from three hospitals. Cox regression analysis was performed on all patients grouped by age.
Adjusted Cox regression showed overall better RA versus SV survival (hazard ratio [HR] 0.82, p < 0.001) and no difference in RITA versus SV survival (HR 0.95, p = 0.35). However, the survival benefit of RA versus SV was seen only in patients aged less than 70 years (HR 0.77, p < 0.001); and RITA patients aged less than 70 years also had a survival benefit compared with SV (HR 0.86, p = 0.03). There was no difference in survival for RA versus RITA across all ages.
For patients aged less than 70 years, the optimal grafting strategy is using either RA or RITA as the second preferred graft. In patients aged 70 years or more, RA and RITA grafting should be used selectively. Multiple arterial grafting using either RA or RITA should be more widely utilized during coronary artery bypass graft surgery for patients less than 70 years of age.
在年龄小于或大于70岁的患者中,使用左乳内动脉(LITA)进行冠状动脉旁路移植手术时,桡动脉(RA)、右乳内动脉(RITA)或大隐静脉(SV)是否为首选的第二条旁路移植血管尚不清楚。
收集了来自三家医院的13324例连续的、孤立的、原发性冠状动脉旁路移植手术患者的晚期生存数据。对所有患者按年龄分组进行Cox回归分析。
调整后的Cox回归显示,总体而言,RA的生存率优于SV(风险比[HR]0.82,p<0.001),而RITA与SV的生存率无差异(HR 0.95,p=0.35)。然而,RA与SV相比的生存获益仅在年龄小于70岁的患者中可见(HR 0.77,p<0.001);年龄小于70岁的RITA患者与SV相比也有生存获益(HR 0.86,p=0.03)。各年龄段RA与RITA的生存率无差异。
对于年龄小于70岁的患者,最佳的移植策略是以RA或RITA作为第二选择的移植血管。对于年龄70岁及以上的患者,应选择性地使用RA和RITA移植。在年龄小于70岁的患者进行冠状动脉旁路移植手术时,应更广泛地采用使用RA或RITA的多动脉移植。